Association of relapse of Clostridium difficile disease with BI/NAP1/027. - Wikidata - wikimedia - TriplyDB

Association of relapse of Clostridium difficile disease with BI/NAP1/027.

Association of relapse of Clostridium difficile disease with BI/NAP1/027.

http://www.wikidata.org/entity/Q36414097

about

Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review Laboratory diagnosis of bacterial gastroenteritis Treatment of Clostridium difficile infection: recent trial results.Clostridium difficile 027/BI/NAP1 encodes a hypertoxic and antigenically variable form of TcdB.Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab Muricholic acids inhibit Clostridium difficile spore germination and growth Exposure of neutralizing epitopes in the carboxyl-terminal domain of TcdB is altered by a proximal hypervariable region.Emergence of an outbreak-associated Clostridium difficile variant with increased virulence.Hyperimmune bovine colostrum as a novel therapy to combat Clostridium difficile infection A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.Risk factors for recurrent hospital-acquired Clostridium difficile infection in a Japanese university hospital.Mechanisms of hypervirulent Clostridium difficile ribotype 027 displacement of endemic strains: an epidemiological model.Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model Colonization of toxigenic Clostridium difficile among ICU patients: a prospective study.Surface layer proteins from virulent Clostridium difficile ribotypes exhibit signatures of positive selection with consequences for innate immune response Environmental Contamination in Households of Patients with Recurrent Clostridium difficile Infection Comparison of multilocus variable-number tandem-repeat analysis and whole-genome sequencing for investigation of Clostridium difficile transmission.Variations in virulence and molecular biology among emerging strains of Clostridium difficile.The rise of Clostridium difficile infection in lung transplant recipients in the modern era.Hyperimmune bovine colostrum for treatment of GI infections: a review and update on Clostridium difficile.Clostridium difficile surveillance: harnessing new technologies to control transmission.Clostridium difficile infection in the postcolectomy patient.An exploratory study to evaluate Clostridium difficile polymerase chain reaction ribotypes and infection outcomes Ambush of Clostridium difficile spores by ramoplanin: activity in an in vitro model An in silico evaluation of treatment regimens for recurrent Clostridium difficile infection.Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection.Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections.Impact of malignancy on Clostridium difficile infection.Vaccination against Clostridium difficile using toxin fragments: Observations and analysis in animal models Clinical and Healthcare Burden of Multiple Recurrences of Clostridium difficile Infection.Molecular epidemiology of Clostridium difficile infections in children: a retrospective cohort study.Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.Risk factors and management of refractory or recurrent clostridium difficile infection in ileal pouch patients.Novel risk factors for recurrent Clostridium difficile infection in children.Control of Clostridium difficile Infection by Defined Microbial Communities.Emerging Trends in "Smart Probiotics": Functional Consideration for the Development of Novel Health and Industrial Applications Risk Factors for Recurrent Clostridium difficile Infections and Strategies to Decrease Readmissions in a Community Hospital.Cost-Effectiveness of Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium Difficile Infection: A Literature Review.Therapeutic approaches for Clostridium difficile infections.Biofilm Structures in a Mono-Associated Mouse Model of Clostridium difficile Infection.

P2860

Q27021390-135787A1-65C7-455D-B87C-BE793DCAA9C9 Q27027754-F8ED7CB5-062F-4FFD-9743-7CDB7E80E133 Q34710368-CDD96EA3-8230-4C2A-82B7-D6B770B2DE89 Q34916871-A02A7366-30FB-4C52-BF38-39656D7A5AEB Q34955629-BD0501FF-2E97-4849-A827-2339ADD0CD83 Q34989047-D2D9D251-77C4-4AB4-AE5F-53A88CC32255 Q35172641-10BE93BD-1A80-422D-B095-7D133F3AC065 Q35193183-841ED7B7-AFF5-4E63-B710-FAA81D7D1631 Q35661928-454E4BA9-E86C-46F6-8DAA-AB6A67C222EF Q35677616-5EB810AE-3A54-4A91-9EE9-14E0D8F9B38F Q35866318-2B174189-6B91-412D-BF14-BA5E8F8098CF Q35896384-CD31A581-9C2C-44D8-8822-68EAAF808152 Q36060123-55985418-9742-40B2-828E-58575FDD2AC7 Q36099373-097250C1-33F4-4909-813F-7B0946B8E6C6 Q36320846-DDF32AEC-657E-47B6-B0B6-59A3466B357C Q36812229-C2AEAF1F-8EF5-463C-A6B3-CB24F5B2CAC0 Q37336232-4BAFE3F0-0946-46E7-A551-039C77E303F8 Q37680481-991D1884-2350-4AA1-84E9-CF5199ED49FD Q38073818-0B266DED-9E21-4713-83C5-744BB62DD4AB Q38084060-BEE524ED-580E-4A1B-AC96-EE4A8CAFAB2C Q38154925-5F11B0B6-0495-40EC-B3EE-7CA5075F135B Q38268703-FF538A87-5711-4190-BA75-2DFD16048D13 Q38844052-F6383EEE-96FF-4AE5-B753-88F3420A1622 Q39564798-7D36405F-3FCF-429E-8B18-A71E4504B16F Q40085926-2CC40D92-3A9C-4ECA-8FDF-3F99D4F5EB66 Q40125340-4F538C48-F1ED-4FAD-9B2E-F7CBE6D106DB Q40543183-CB0DFFB4-BB25-4FE2-9851-42C333EE3EF5 Q40598769-8BAD8A73-298B-4A50-A382-1BE5B8A3EDD0 Q40899692-36A03AB4-8CDA-4466-9B36-7710E6009E07 Q40904612-602FF6C4-17B0-42E6-AA48-F05CBA595EF7 Q41419841-E741383A-0FB8-450A-ADAB-3BCAC80D459B Q41475748-A0194C44-66B8-4596-826F-E0104011EF11 Q41739117-D451338B-E424-457A-AA7E-CE86ECC50304 Q41749209-88D1A062-FC61-484C-8649-87231C71D646 Q41932327-6BC2BA4C-5B36-4CC6-AB6C-80A44D950D4C Q42369781-0EA28470-B015-4BBA-9AD2-42CB694C24F8 Q42564214-2A3DCB3D-B404-48E3-87CE-A2FFDA0E01C8 Q42649836-0F72E963-5B61-47BF-8BB6-3A4FCFF8B616 Q45406068-E70C3B6A-F286-449E-8BE8-C5B61264F837 Q47181928-E285CBE6-2A5C-4E83-984C-F2E4F5EEFDD3

P2860

Association of relapse of Clostridium difficile disease with BI/NAP1/027.

http://www.wikidata.org/entity/Q36414097

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Association of relapse of Clostridium difficile disease with BI/NAP1/027.

@ast

Association of relapse of Clostridium difficile disease with BI/NAP1/027.

@en

type

label

Association of relapse of Clostridium difficile disease with BI/NAP1/027.

@ast

Association of relapse of Clostridium difficile disease with BI/NAP1/027.

@en

prefLabel

Association of relapse of Clostridium difficile disease with BI/NAP1/027.

@ast

Association of relapse of Clostridium difficile disease with BI/NAP1/027.

@en

P1433

Q36414097-9494939A-02AB-4251-AD0B-E0AE9F71B8B9

P1476

Q36414097-99D6E078-1D45-4B32-8A91-C89BF4375AB4

P2093

Q36414097-1209560C-90B2-4EF1-A744-F36B77321CBA

Q36414097-2C93169E-69D1-4B10-A124-D0186A8D3F9B

Q36414097-579B28C9-8A84-401F-B924-BEECE7E36E68

Q36414097-F8B7B256-CC46-413F-86DD-76BECC7B5ADA

Q36414097-FB9465A9-1D48-450F-9059-C3862B13853B

P2860

Q36414097-0D5BB8E4-AA99-4932-9D29-8ECC4FB09274

Q36414097-1233B45D-F7B4-436B-8609-E76337E3452A

Q36414097-1E8345CD-935E-4818-AE44-51977B8A0A12

Q36414097-1F85F4A0-4BEA-4F93-B953-321E5E8B0292

Q36414097-2AD1EE41-94FC-45A5-9F6E-0159D7B70810

Q36414097-2B52CBAD-D3C9-4EFB-A90D-84CB52F3A365

Q36414097-36028200-5D65-4A2D-8339-C55E9F34CBEB

Q36414097-47A0DB1A-06B5-44C6-9FAC-E9BBE8935E5F

Q36414097-50383D59-BE81-40F0-B270-D100CC570EA5

Q36414097-5DABBF9B-C94C-46FC-AB0C-C5FEA6346E58

P304

Q36414097-F55297FB-BC05-466B-A53F-A2422B83C481

P31

Q36414097-2ECF24DE-2CD6-4812-863B-D0261685ADCA

P356

Q36414097-9C35E74F-BD69-45BE-B394-2B92DB0805B2

P407

Q36414097-05E49CCE-726F-49C2-990B-CFC1DABD155D

P433

Q36414097-FC73D834-BF3E-443C-A0B1-AD65F3F2FE5B

P478

Q36414097-620A2F1F-B4C6-4EDA-BBFF-819A078AA049

P50

Q36414097-6E663F72-1AA6-43F4-97D9-C53E75D89995

P577

Q36414097-0C731FB6-9CD0-4E62-9902-FE919BC0061E

P698

Q36414097-9D341ACB-434C-49AB-BEB8-9287AB640A32

P921

Q36414097-630FD2A7-9C93-41E5-97AB-6D6181E02C72

P932

Q36414097-F3E6BB41-FEEA-4329-A226-D6C8F45DD78E

P356

P1433

Journal of Clinical Microbiology

P1476

Association of relapse of Clostridium difficile disease with BI/NAP1/027.

@en

P2093

Jane W Marsh

http://www.w3.org/2001/XMLSchema#string

Jessica L Schlackman

http://www.w3.org/2001/XMLSchema#string

Lee H Harrison

http://www.w3.org/2001/XMLSchema#string

Rangolee Arora

http://www.w3.org/2001/XMLSchema#string

Scott R Curry

http://www.w3.org/2001/XMLSchema#string

P2860

Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting.

Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study

Clinical Clostridium difficile: clonality and pathogenicity locus diversity.

Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea.

Fidaxomicin versus vancomycin for Clostridium difficile infection.

Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals

Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.

Relapse versus reinfection: surveillance of Clostridium difficile infection.

tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile.

Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.

P304

4078-4082

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.02291-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Kathleen A. Shutt

P577

2012-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23052318

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

3502988

http://www.w3.org/2001/XMLSchema#string